507 Shares in Synopsys, Inc. $SNPS Purchased by Elevation Point Wealth Partners LLC

Elevation Point Wealth Partners LLC bought a new stake in Synopsys, Inc. (NASDAQ:SNPSFree Report) during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund bought 507 shares of the semiconductor company’s stock, valued at approximately $260,000.

A number of other hedge funds and other institutional investors have also made changes to their positions in the company. Saudi Central Bank acquired a new position in Synopsys in the first quarter valued at approximately $26,000. Clal Insurance Enterprises Holdings Ltd raised its position in Synopsys by 441.7% in the first quarter. Clal Insurance Enterprises Holdings Ltd now owns 65 shares of the semiconductor company’s stock valued at $28,000 after purchasing an additional 53 shares during the period. Independence Bank of Kentucky lifted its stake in shares of Synopsys by 120.0% in the 2nd quarter. Independence Bank of Kentucky now owns 55 shares of the semiconductor company’s stock valued at $28,000 after purchasing an additional 30 shares during the last quarter. Princeton Global Asset Management LLC grew its holdings in shares of Synopsys by 481.8% during the 2nd quarter. Princeton Global Asset Management LLC now owns 64 shares of the semiconductor company’s stock worth $33,000 after purchasing an additional 53 shares during the period. Finally, WPG Advisers LLC acquired a new stake in shares of Synopsys during the 1st quarter worth about $34,000. Institutional investors and hedge funds own 85.47% of the company’s stock.

Analysts Set New Price Targets

A number of research analysts have commented on the stock. Stifel Nicolaus decreased their target price on shares of Synopsys from $650.00 to $550.00 and set a “buy” rating on the stock in a research report on Wednesday, September 10th. Weiss Ratings reissued a “hold (c)” rating on shares of Synopsys in a research note on Wednesday, October 8th. Citigroup started coverage on shares of Synopsys in a report on Monday, November 24th. They issued a “buy” rating and a $580.00 price objective on the stock. Piper Sandler dropped their target price on shares of Synopsys from $660.00 to $630.00 and set an “overweight” rating for the company in a report on Wednesday, September 10th. Finally, The Goldman Sachs Group cut their target price on Synopsys from $700.00 to $600.00 and set a “buy” rating on the stock in a research report on Wednesday, September 10th. Ten analysts have rated the stock with a Buy rating, six have given a Hold rating and two have assigned a Sell rating to the company. According to MarketBeat.com, Synopsys currently has an average rating of “Hold” and an average target price of $556.33.

Read Our Latest Analysis on SNPS

Synopsys Stock Up 2.0%

Synopsys stock opened at $417.99 on Friday. The firm has a market capitalization of $77.64 billion, a P/E ratio of 32.81, a P/E/G ratio of 5.02 and a beta of 1.10. The company has a current ratio of 1.62, a quick ratio of 1.51 and a debt-to-equity ratio of 0.52. Synopsys, Inc. has a twelve month low of $365.74 and a twelve month high of $651.73. The stock’s fifty day simple moving average is $440.31 and its 200-day simple moving average is $507.40.

Synopsys (NASDAQ:SNPSGet Free Report) last released its earnings results on Tuesday, September 9th. The semiconductor company reported $2.30 EPS for the quarter, missing the consensus estimate of $3.75 by ($1.45). Synopsys had a return on equity of 10.82% and a net margin of 31.04%.The company had revenue of $1.74 billion for the quarter, compared to analyst estimates of $1.77 billion. During the same period in the previous year, the firm earned $3.43 earnings per share. The company’s revenue for the quarter was up 14.0% compared to the same quarter last year. Synopsys has set its FY 2025 guidance at 12.760-12.800 EPS. Q4 2025 guidance at 2.760-2.80 EPS. As a group, equities analysts expect that Synopsys, Inc. will post 10.64 earnings per share for the current fiscal year.

Insider Activity

In other Synopsys news, CFO Shelagh Glaser sold 3,655 shares of the business’s stock in a transaction that occurred on Friday, September 5th. The shares were sold at an average price of $609.77, for a total transaction of $2,228,709.35. Following the completion of the transaction, the chief financial officer owned 15,317 shares in the company, valued at $9,339,847.09. The trade was a 19.27% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, CEO Sassine Ghazi sold 11,366 shares of the firm’s stock in a transaction on Tuesday, September 2nd. The shares were sold at an average price of $589.01, for a total transaction of $6,694,687.66. Following the completion of the sale, the chief executive officer owned 71,615 shares in the company, valued at $42,181,951.15. The trade was a 13.70% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 30,894 shares of company stock valued at $16,760,783 over the last three months. 0.62% of the stock is currently owned by corporate insiders.

Synopsys Profile

(Free Report)

Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.

Featured Articles

Institutional Ownership by Quarter for Synopsys (NASDAQ:SNPS)

Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.